COLLEEN O'KEEFFE: Open Payments
NPI 1366943755 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 42 payments from 8 companies in 2025. Trend: 2023 $87 · 2024 $571 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $265 |
| Novartis Pharmaceuticals Corporation | 20 | $231 |
| E.R. Squibb & Sons, L.L.C. | 10 | $191 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| BridgeBio Pharma, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: Rapiblyk, LEQVIO, CAMZYOS, VERQUVO, Attruby, FARXIGA, ONPATTRO, ELIQUIS.
Industry payments across NY — which companies pay providers there.
